211 related articles for article (PubMed ID: 35782114)
1. Bioinformatics Analysis Highlights Five Differentially Expressed Genes as Prognostic Biomarkers of Cervical Cancer and Novel Option for Anticancer Treatment.
Cui H; Ma R; Hu T; Xiao GG; Wu C
Front Cell Infect Microbiol; 2022; 12():926348. PubMed ID: 35782114
[TBL] [Abstract][Full Text] [Related]
2. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma.
Zhang L; Nan F; Yang L; Dong Y; Tian Y
J Obstet Gynaecol Res; 2022 Jul; 48(7):1848-1858. PubMed ID: 35491469
[TBL] [Abstract][Full Text] [Related]
4. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
5. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
[TBL] [Abstract][Full Text] [Related]
7. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
9. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
[TBL] [Abstract][Full Text] [Related]
12. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
13. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
14. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
[TBL] [Abstract][Full Text] [Related]
17. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.
Wang D; Liu Y; Cheng S; Liu G
Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744
[TBL] [Abstract][Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
